Antibiotic resistance is increasing worldwide, especially among ocular pathogens and one of the major reasons for this severity is the formation of biofilm which causes antibacterial specialists like Ciprofloxacin HCl to be ineffective, but combining it with substances that inhibit quorum sensing, a process that leads towards the development of biofilm, such as Quercetin, in a single formulation is an effective way to treat these infections. Aiming to develop and approve a new analytical method for the simultaneous evaluation of ciprofloxacin HCl and quercetin in their mass powder, the current examination is expected to accomplish this. Two strategies—the simultaneous equation approach (I) and the absorbance ratio method (II)—were created and validated in accordance with ICH guidelines for specificity, selectivity, linearity, precision, and accuracy. Quercetin's and Ciprofloxacin HCl's absorbance maxima (λmax) were determined to be at 327 nm and 271 nm, respectively, with coefficient correlation values of 0.999 and 0.997. Their isosbestic point was noticed at a maximum wavelength of 283 nm. Both Ciprofloxacin HCl and Quercetin demonstrated linearity in the focus range from 1 µg/ml to 10 µg/ml when absorbances were measured at any of the aforementioned levels. It was discovered that the developed processes were exact and precise with less than 2% relative standard deviation (%RSD). %Recovery studies were found to be 98.62-101.15% for Ciprofloxacin HCl at 271nm, 99.34-100.94% for Quercetin at 327nm, 99.63-104.62%, and 101.23-102.64% for Ciprofloxacin HCl and Quercetin respectively at their isosbestic point. Because it was discovered to be simple, rapid, specific, selective, linear, exact, and based on absorptivity measurements, the established UV Spectrophotometric technique can be used for in vitro depiction and contemporaneous assessment of Ciprofloxacin HCl and Quercetin.
Read full abstract